John Conlon - Concepedia

Author

John Conlon

Also Known As

J C Conlon, J Conlon, J. Conlon, John Conlon

Publications

231

Citations

H-Index

Concepts

All Affiliations

John Conlon is an author at Frederick National Laboratory for Cancer Research specializing in medicine, pharmacotherapy, and radiation oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	52
2	Cell Biology	1	1	26
3	Cellular Physiology	1	1	26
4	Immunology	1	1	26
5	Pharmacology	1	1	26

John Conlon

Publications

216

Citations

H-Index

Page 1

	Year	Citations
Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. A E Maluish, John R. Ortaldo, John Conlon, The Journal of Immunology	1983	102
Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging Luc Douay, Chen Hu, MC Giarratana, Blood	1995	62
Characterization of biological response modifier release by human monocytes cultured in suspension in serum-free medium Henry C. Stevenson, Eric Schlick, Richard Griffith, Journal of Immunological Methods InflammationSerum-free MediumImmunologyCell CultureMedicine	1984	26
WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells David S. Alberts, L A Speicher, Mary F. Krutzsch, European Journal of Cancer Cytotoxic EffectsStandard Anticancer DrugsOncologyMedicineBreast Cancer Cells	1996	26

Page 1